| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/26/2006 | WO2006030126A3 Method of accelerating somatic mutations and use thereof in proteomics |
| 05/26/2006 | WO2006028930A3 Combinatorial artificial receptors including tether building blocks on scaffolds |
| 05/26/2006 | WO2006027117A3 Diagnostics and therapeutics for diseases associated with cysteinyl leukotriene receptor 2 (cyslt2) |
| 05/26/2006 | WO2006018736A3 Use of golden hamster as infectivity model of sars |
| 05/26/2006 | WO2006017149A3 Systems and methods for detecting living organisms in sediments and rocks |
| 05/26/2006 | WO2006010369A3 Methods for determining proteins and protein-bound compounds comprising enzymatic modification |
| 05/26/2006 | WO2006008760A3 A method of diagnosing tuberculosis |
| 05/26/2006 | WO2006008007A3 Diagnostics and therapeutics for diseases associated with retinoid-inducible serine carboxypeptidase (risc) |
| 05/26/2006 | WO2006003179A3 Antibodies binding to receptors kir2dl1, -2, 3 but not kir2ds4 and their therapeutic use |
| 05/26/2006 | WO2005124360A3 Use of protein tebp as a marker for breast cancer |
| 05/26/2006 | WO2005120518A3 Use of atp analogues for treatment of cardiovascular diseases |
| 05/26/2006 | WO2005119251A3 Novel means and methods for the treatment of hearing loss and phantom hearing |
| 05/26/2006 | WO2005116658A3 Method for determining a tissue degradation process by detection of comp neoepitopes |
| 05/26/2006 | WO2005116657A3 Identification of ergothioneine transporter and therapeutic uses thereof |
| 05/26/2006 | WO2005115478A3 Methods and compositions for autism spectrum disorders |
| 05/26/2006 | WO2005114198A3 Protein phosphorylation assay |
| 05/26/2006 | WO2005113817A3 Aptamer-nanoparticle conjugates and method of use for target analyte detection |
| 05/26/2006 | WO2005112619A3 Novel gene disruptions, compositions and methods relating thereto |
| 05/26/2006 | WO2005108987A3 Determination of osteoprotegerin for the prognosis of cardiovascular disorders |
| 05/26/2006 | WO2005106013A3 Use of mdck cell line to predict corneal penetration of drugs |
| 05/26/2006 | WO2005104836A3 Drosophila models for diseases affecting learning and memory |
| 05/26/2006 | WO2005104785A3 Methods and compositions for specifically targeting human hepatocellular carcinoma cells |
| 05/26/2006 | WO2005098429A3 System and method for real-time diagnosis, treatment, and therapeutic drug monitoring |
| 05/26/2006 | WO2005075022A3 Susceptibility gene for myocardial infraction, stroke, and paod; methods of treatment |
| 05/26/2006 | WO2005074633A3 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
| 05/26/2006 | WO2005069943A3 Method and apparatus for calibrating a frequency domain reflectometer |
| 05/26/2006 | WO2005069889A3 Hydroxyl functional surface coating |
| 05/26/2006 | WO2005068996A3 Phased micro analyzer iv |
| 05/26/2006 | WO2005043465A3 Stereo display of tube-like structures and improved techniques therefor ('stereo display') |
| 05/26/2006 | WO2005031509A3 System and method for continuous data analysis of an ongoing clinical trial |
| 05/26/2006 | WO2005030933A3 Bone morphogenetic protein (bmp)-7 based diagnosis and treatment of cancer |
| 05/26/2006 | WO2005028621A3 Assays with primary cells |
| 05/26/2006 | WO2004084835A3 Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor |
| 05/26/2006 | WO2004081567A8 Organic substance immobilizing chip and its use |
| 05/26/2006 | WO2004037204A3 Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease |
| 05/26/2006 | CA2838007A1 A method for single oxygen atom incorporation into digested peptides using peptidases |
| 05/26/2006 | CA2790433A1 Anti-addl antibodies and uses thereof |
| 05/26/2006 | CA2588646A1 Methods to identify ligands of hormone nuclear receptors |
| 05/26/2006 | CA2588066A1 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 05/26/2006 | CA2587948A1 Tnf antagonists |
| 05/26/2006 | CA2587886A1 Method of screening candidate drug |
| 05/26/2006 | CA2587885A1 Human serum for cell culture |
| 05/26/2006 | CA2587765A1 Magnetic enrichment of circulating cells, fragments and debris for enabling hts proteomics and genomics in disease detection |
| 05/26/2006 | CA2587716A1 Hcv f protein and uses thereof |
| 05/26/2006 | CA2587398A1 Gpr7-selective ligand and use thereof |
| 05/26/2006 | CA2587380A1 Methods and systems for positioning microspheres for imaging |
| 05/26/2006 | CA2586615A1 Pro87299 (btla), and variants thereof, for treating immune related disorders |
| 05/26/2006 | CA2586408A1 A testing method of nucleic acid binding protein based on biochip |
| 05/26/2006 | CA2586130A1 Reagent containing oxygen isotope-labeled hemoglobin for examining vital tissue and method of producing the same |
| 05/26/2006 | CA2585985A1 Methods of developing a stem cell line |
| 05/26/2006 | CA2585784A1 Methods of determining human egg competency |
| 05/26/2006 | CA2584619A1 Amide compound |
| 05/26/2006 | CA2582135A1 Fluorescence polarization assay for determining histidine decarboxylase activity |
| 05/26/2006 | CA2579478A1 Detection of intact recombinant viruses |
| 05/26/2006 | CA2576998A1 Use of c3a and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; diagnosis method and test system using the same |
| 05/25/2006 | WO2006008126B1 Novel use of the kinases RSK4 and PAK5 |
| 05/25/2006 | WO2005111622A9 Diagnostic assay for trypanosoma cruzi infection |
| 05/25/2006 | US20060112440 Fluorescent protein sensors for detection of analytes |
| 05/25/2006 | US20060112437 Transgenic animal expressing alzheimer's tau protein |
| 05/25/2006 | US20060111848 Identification and use of cofactor independent phosphoglycerate mutase as a drug target for pathogenic organisms and treatment of the same |
| 05/25/2006 | US20060111564 Photoactivatable two-stage protective groups for the synthesis of biopolymers |
| 05/25/2006 | US20060111556 Preventives/remedies for neurodegenerative diseases |
| 05/25/2006 | US20060111517 Recognition layers made of hydrogel based on polyacrylamide for use in biosensor technology |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111294 Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells |
| 05/25/2006 | US20060111287 Acetylated protein |
| 05/25/2006 | US20060111283 Prevention therapy and prognosis/monitoring in sepsis and septic shock |
| 05/25/2006 | US20060110833 Method and apparatus for coupling an analyte supply to an electrodynamic droplet processor |
| 05/25/2006 | US20060110832 Methods and systems for discovering protein modifications and mutations |
| 05/25/2006 | US20060110831 Capsule chemistry technology utilizes an oil-based segmented-flow technique combined with a noninvasive method to combine and mix each sample aliquot with the required reagents for the specific analytical test; noninvasive technology is achieved by sophisticated microhydraulics |
| 05/25/2006 | US20060110826 Methods for perfusion and plating of primary hepatocytes and a medium therefore |
| 05/25/2006 | US20060110821 Devices for motile sperm separation |
| 05/25/2006 | US20060110819 Apparatus and method for expression and capture of biomolecules and complexes on adsorbent surfaces |
| 05/25/2006 | US20060110803 Antigenic peptides of SARS coronavirus and uses thereof |
| 05/25/2006 | US20060110794 Peptides from the E2 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
| 05/25/2006 | US20060110792 Potassium channels, nucleotide sequences encoding them, and methods of using same |
| 05/25/2006 | US20060110786 kits for discriminating between COX-1 and COX-2 activity; screening for a tumor, monitoring anticancer treatment or antiinflammatory treatment; less invasive; 2-arachidonylglycerol is a substrate of the COX-2 enzyme, but not COX-1 |
| 05/25/2006 | US20060110784 Site-specific labeling of proteins for NMR studies |
| 05/25/2006 | US20060110783 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a) |
| 05/25/2006 | US20060110781 Cholesterol detection reagent |
| 05/25/2006 | US20060110780 Plasma C5a levels as an indicator of asthma severity |
| 05/25/2006 | US20060110779 Method for detecting a lectin-like substance |
| 05/25/2006 | US20060110778 High-throughput screen for identifying selective persistent sodium channels channel blockers |
| 05/25/2006 | US20060110777 Structured peptide scaffold for displaying turn libraries on phage |
| 05/25/2006 | US20060110776 Monoclonal antibodies for binding to native proBNP to diagnose heart failure and hybridomas to produce antibodies |
| 05/25/2006 | US20060110775 Monoclonal antibodies for binding to native proBNP to diagnose heart failure and hybridomas to produce antibodies |
| 05/25/2006 | US20060110774 Methods for detecting sepsis |
| 05/25/2006 | US20060110773 Marker for inflammatory conditions |
| 05/25/2006 | US20060110772 Human and murine cytokine polypeptides |
| 05/25/2006 | US20060110771 Proteins capable of binding to female sex hormones and process for producing the same |
| 05/25/2006 | US20060110754 Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology |
| 05/25/2006 | US20060110753 Methods to diagnose and treat lung cancer |
| 05/25/2006 | US20060110750 Structure-specific nuclease activity of a variety of enzymes is used to cleave the target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations |
| 05/25/2006 | US20060110747 Process for improved protein expression by strain engineering |
| 05/25/2006 | US20060110746 Treatment of cancer using TLR3 agonists |
| 05/25/2006 | US20060110739 Biosensors for detecting macromolecules and other analytes |
| 05/25/2006 | US20060110737 Human tumor-associated gene ct120 on chromosome 17p 13.3 region and the protein encoded by it |
| 05/25/2006 | US20060110735 Use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity |
| 05/25/2006 | US20060110732 Method for the identification of ligands |